Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial

Journal:

The Lancet Oncology

Published:

2025-06-19

DOI:

10.1016/s1470-2045(25)00233-5

Affiliations:

19

Authors:

21

Go to article

Institutions	Authors	Share
Juntendo University, Japan	4.000000	0.19
Gifu University Hospital, Japan	2.000000	0.10
Shizuoka General Hospital, Japan	1.500000	0.07
Juntendo University Main Hospital, Japan	1.000000	0.05
Omori Medical Center, Toho University, Japan	1.000000	0.05
National Cancer Center Hospital, Japan	1.000000	0.05
Yamaguchi University, Japan	1.000000	0.05
Sapporo Medical University Hospital, Japan	1.000000	0.05
Iwate Medical University, Japan	1.000000	0.05
Juntendo University Urayasu Hospital, Japan	1.000000	0.05
Tokyo Medical University, Japan	1.000000	0.05
University of Tsukuba, Japan	1.000000	0.05
Tottori University Hospital, Japan	1.000000	0.05
Juntendo University Shizuoka Hospital, Japan	1.000000	0.05
National Cancer Center Hospital East, Japan	1.000000	0.05
Shikoku Cancer Center, Japan	1.000000	0.05
Juntendo University Nerima Hospital, Japan	0.500000	0.02

Interested in Oncology and Carcinogenesis?